春蘭大醫(yī)學免疫學B

1、單選題兄弟姐妹間進行器官移植引起排斥反應的物質(zhì)屬A: <span>異種抗原 </span>B: <span>同種異型抗原</span>C: <span>自身抗原 </span>D: <span>異嗜性抗原</span>E: <span>細菌感染</span>單選題我國兒童計劃免疫程序規(guī)定出生24小時內(nèi)接種的疫苗是A: <span>脊灰疫苗+卡介苗 </span>B: <span>乙型肝炎疫苗+卡介苗 </span>C: <

2、span>百白破疫苗+卡介苗</span>D: <span>麻疹疫苗+乙型肝炎疫苗+卡介苗 </span>E: <span>乙腦疫苗+乙型肝炎疫苗+卡介苗</span>單選題細胞之間相互作用不受MHC限制的是A: <span> CTL殺傷腫瘤細胞 </span>B: <span> CTL殺傷病毒感染細胞 </span>C: <span> DC向Th細胞提呈抗原 </span>D: <span> 活化的巨噬細胞殺傷腫瘤細胞 </span>

3、;E: <span> 巨噬細胞向Th細胞提呈抗原</span>單選題IgG分子中能與C1q結(jié)合的功能區(qū)是A: <span>CH1</span>B: <span>CH2</span>C: <span>CH3</span>D: <span>VH</span>E: <span>VL</span>單選題脾內(nèi)T細胞主要分布于A: <span>脾小結(jié)</span>B: <span>邊緣區(qū)</span>C: <s

4、pan>白髓</span>D: <span>紅髓</span>E: <span>血竇</span>單選題下列物質(zhì)中歸屬于隱蔽性抗原的是A: <span>ABO血型抗原</span>B: <span>主要組織相容性抗原</span>C: <span>Rh血型抗原</span>D: <span>免疫球蛋白同種異型抗原</span>E: <span>眼葡萄膜色素蛋白</span>單選題T細胞抗原識別受體是A: <

5、;span>BCR </span>B: <span>PRR </span>C: <span>TCR </span>D: <span>CDR </span>E: <span>CKR</span>單選題最早合成的免疫球蛋白為A: <span>IgG</span>B: <span> IgM </span>C: <span> IgA</span>D: <span> IgD </span>E: &

6、lt;span> IgE</span>單選題補體旁路途徑激活過程中所不涉及的補體組分是A: <span>C3</span>B: <span>C4</span>C: <span>C5</span>D: <span>C6</span>E: <span>C7</span>單選題動物來源的破傷風抗毒素對人而言是A: <span>半抗原 </span>B: <span>抗體 </span>C: <span>抗

7、原 </span>D: <span>既是抗體又是抗原 </span>E: <span>超抗原 </span>單選題屬于人工被動免疫的措施是A: <span>注射抗毒素獲得的免疫 </span>B: <span>通過胎盤或初乳獲得的免疫</span>C: <span>注射類毒素獲得的免疫 </span>D: <span>傳染病痊愈后獲得的免疫 </span>E: <span>注射疫苗獲得的免疫</span>單選題TCR

8、識別抗原的信號傳遞是通過A: <span>CD2 </span>B: <span>CD8 </span>C: <span>CD4 </span>D: <span>CD79 </span>E: <span>CD3</span>單選題半抗原A: <span>為多價抗原</span>B: <span>通常是蛋白質(zhì)</span>C: <span>只有免疫原性</span>D: <span>為單價抗原&

9、lt;/span>E: <span>通常為隱蔽性抗原</span>單選題屬于遲發(fā)型超敏反應的皮膚試驗是A: <span>青霉素皮膚試驗t</span>B: <span>塵螨皮膚實驗t</span>C: <span>抗毒素皮膚試驗t</span>D: <span>OT或PPD試驗t</span>E: <span>類Arthus反應</span>單選題巨球蛋白是指A: <span> IgG</span>B: <span&

10、gt; IgM </span>C: <span> IgA</span>D: <span> IgD </span>E: <span> IgE</span>單選題同一種屬不同個體之間存在的MHC抗原是A: <span>異種抗原</span>B: <span>同種異型抗原</span>C: <span>自身抗原</span>D: <span>外源性抗原</span>E: <span>異嗜性抗原</span

11、>單選題B細胞表面的BCR輔助受體是A: <span>CD21</span>B: <span>CD19</span>C: <span>Ig/Ig異二聚體</span>D: <span>CD80/86(B7-1/2)</span>E: <span>CD19-CD21-CD81復合體</span>單選題干擾素的作用特點是A: <span>無種屬特異性</span>B: <span>可直接抑制病毒的復制</span>C: <

12、;span>由感染機體的病毒合成</span>D: <span>具有抗病毒和免疫調(diào)節(jié)作用</span>E: <span>屬于多糖類物質(zhì)</span>單選題介導I型超敏反應的抗體是A: <span>IgG類抗體</span>B: <span>IgE類抗體</span>C: <span>IgA類抗體</span>D: <span>IgD類抗體</span>E: <span>IgM類抗體</span>單選題人類B細胞

13、分化發(fā)育成熟的場所是A: <span>胸腺</span>B: <span>骨髓</span>C: <span>淋巴結(jié)</span>D: <span>扁桃體</span>E: <span>腔上囊</span>單選題適應性免疫應答的過程不包括A: <span>抗原提呈細胞對抗原的加工提呈</span>B: <span>T、B細胞對抗原的特異性識別</span>C: <span>T、B細胞的活化增殖和分化</span

14、>D: <span>效應T細胞和抗體等免疫效應分子的產(chǎn)生</span>E: <span>NK細胞的活化及其對腫瘤細胞的殺傷作用</span>單選題IgG的重鏈稱為A: <span>鏈</span>B: <span>鏈</span>C: <span>鏈</span>D: <span>鏈</span>E: <span>鏈</span>單選題患者多次輸血后發(fā)生非溶血性輸血反應的原因是A: <span>患者體內(nèi)產(chǎn)生了抗

15、自身HLA-I類抗原的特異性抗體</span>B: <span>患者體內(nèi)產(chǎn)生了抗供者HLA-I類抗原的特異性抗體</span>C: <span>患者體內(nèi)產(chǎn)生了抗自身HLA-II類抗原的特異性抗體</span>D: <span>患者與供者ABO血型不符</span>E: <span>患者與供者Rh抗原不符</span>單選題在感染后4小時內(nèi)發(fā)揮強大吞噬殺菌作用的免疫細胞是A: <span>NK細胞</span>B: <span>單核細胞</span

16、>C: <span>巨噬細胞</span>D: <span>中性粒細胞</span>E: <span>樹突狀細胞</span>單選題抗原分子中的構(gòu)象表位A: <span>多位于抗原分子內(nèi)部</span>B: <span>是隱蔽性抗原表位</span>C: <span>是T細胞主要識別的表位</span>D: <span>是B細胞主要識別的表位</span>E: <span>是被抗原提呈細胞加工后形成的抗原表位&

17、lt;/span>單選題兄弟姐妹間進行器官移植引起排斥反應的物質(zhì)屬A: <span>異種抗原 </span>B: <span>同種異型抗原</span>C: <span>自身抗原 </span>D: <span>異嗜性抗原</span>E: <span>細菌感染</span>單選題我國兒童計劃免疫程序規(guī)定出生24小時內(nèi)接種的疫苗是A: <span>脊灰疫苗+卡介苗 </span>B: <span>乙型肝炎疫苗+卡介苗 </spa

18、n>C: <span>百白破疫苗+卡介苗</span>D: <span>麻疹疫苗+乙型肝炎疫苗+卡介苗 </span>E: <span>乙腦疫苗+乙型肝炎疫苗+卡介苗</span>單選題細胞之間相互作用不受MHC限制的是A: <span> CTL殺傷腫瘤細胞 </span>B: <span> CTL殺傷病毒感染細胞 </span>C: <span> DC向Th細胞提呈抗原 </span>D: <span> 活化的巨噬細胞殺傷腫瘤細胞

19、</span>E: <span> 巨噬細胞向Th細胞提呈抗原</span>單選題IgG分子中能與C1q結(jié)合的功能區(qū)是A: <span>CH1</span>B: <span>CH2</span>C: <span>CH3</span>D: <span>VH</span>E: <span>VL</span>單選題脾內(nèi)T細胞主要分布于A: <span>脾小結(jié)</span>B: <span>邊緣區(qū)</span

20、>C: <span>白髓</span>D: <span>紅髓</span>E: <span>血竇</span>單選題下列物質(zhì)中歸屬于隱蔽性抗原的是A: <span>ABO血型抗原</span>B: <span>主要組織相容性抗原</span>C: <span>Rh血型抗原</span>D: <span>免疫球蛋白同種異型抗原</span>E: <span>眼葡萄膜色素蛋白</span>單選題T細胞抗

21、原識別受體是A: <span>BCR </span>B: <span>PRR </span>C: <span>TCR </span>D: <span>CDR </span>E: <span>CKR</span>單選題最早合成的免疫球蛋白為A: <span>IgG</span>B: <span> IgM </span>C: <span> IgA</span>D: <span> IgD </

22、span>E: <span> IgE</span>單選題補體旁路途徑激活過程中所不涉及的補體組分是A: <span>C3</span>B: <span>C4</span>C: <span>C5</span>D: <span>C6</span>E: <span>C7</span>單選題動物來源的破傷風抗毒素對人而言是A: <span>半抗原 </span>B: <span>抗體 </span>C: &

23、lt;span>抗原 </span>D: <span>既是抗體又是抗原 </span>E: <span>超抗原 </span>單選題屬于人工被動免疫的措施是A: <span>注射抗毒素獲得的免疫 </span>B: <span>通過胎盤或初乳獲得的免疫</span>C: <span>注射類毒素獲得的免疫 </span>D: <span>傳染病痊愈后獲得的免疫 </span>E: <span>注射疫苗獲得的免疫</sp

24、an>單選題TCR識別抗原的信號傳遞是通過A: <span>CD2 </span>B: <span>CD8 </span>C: <span>CD4 </span>D: <span>CD79 </span>E: <span>CD3</span>單選題半抗原A: <span>為多價抗原</span>B: <span>通常是蛋白質(zhì)</span>C: <span>只有免疫原性</span>D: <sp

25、an>為單價抗原</span>E: <span>通常為隱蔽性抗原</span>單選題屬于遲發(fā)型超敏反應的皮膚試驗是A: <span>青霉素皮膚試驗t</span>B: <span>塵螨皮膚實驗t</span>C: <span>抗毒素皮膚試驗t</span>D: <span>OT或PPD試驗t</span>E: <span>類Arthus反應</span>單選題巨球蛋白是指A: <span> IgG</span>

26、B: <span> IgM </span>C: <span> IgA</span>D: <span> IgD </span>E: <span> IgE</span>單選題同一種屬不同個體之間存在的MHC抗原是A: <span>異種抗原</span>B: <span>同種異型抗原</span>C: <span>自身抗原</span>D: <span>外源性抗原</span>E: <span>異嗜

27、性抗原</span>單選題B細胞表面的BCR輔助受體是A: <span>CD21</span>B: <span>CD19</span>C: <span>Ig/Ig異二聚體</span>D: <span>CD80/86(B7-1/2)</span>E: <span>CD19-CD21-CD81復合體</span>單選題干擾素的作用特點是A: <span>無種屬特異性</span>B: <span>可直接抑制病毒的復制</sp

28、an>C: <span>由感染機體的病毒合成</span>D: <span>具有抗病毒和免疫調(diào)節(jié)作用</span>E: <span>屬于多糖類物質(zhì)</span>單選題介導I型超敏反應的抗體是A: <span>IgG類抗體</span>B: <span>IgE類抗體</span>C: <span>IgA類抗體</span>D: <span>IgD類抗體</span>E: <span>IgM類抗體</span>單選題人類B細胞分化發(fā)育成熟的場所是A: <span>胸腺</span>B: <span>骨髓</span>C: <span>淋巴結(jié)</span>D: <span>扁桃體</span>E: <span>腔上囊</span>單選題適應性免疫應答的過程不包括A: <span>抗原提呈細胞對抗原的加工提呈</span>B: <span>T、B細胞對抗原的特異性識別